Hodgkin Lymphoma: Clinical Trials

36 trials for Hodgkin Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 5 recruiting, 5 terminated, 4 active not recruiting. 36 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable36Completed 19, Recruiting 5, Terminated 5, Active not recruiting 4, Not yet recruiting 1, Unknown 1, Withdrawn 1

Follow Hodgkin Lymphoma: new trials by email Literature Review of Hodgkin Lymphoma trials Research Report on Hodgkin Lymphoma

Trials (filtered) newest first · largest first

All 36 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
Ossium HPC, Marrow, Standard of care living donor - Haplo Related, Standard of care living donor - Mismatched Unrelated - Hematologic Malignancy, Acute Leukemia
Not applicableNot yet recruitingOssium Health, Inc.3002026-12-012026-09-10
Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Proton Therapy (Adaptive) - Pediatric Solid Tumors, Rhabdomyosarcoma
Not applicableRecruitingSt. Jude Children's Research Hospital1002026-08-202026-08-21
Feasibility of High Intensity Interval Training in Survivors of Childhood, Adolescent, and Young Adult Hodgkin Lymphoma
High Intensity Interval Training (HIIT) - Hodgkin Lymphoma
Not applicableRecruitingSt. Jude Children's Research Hospital202026-06-082026-06-10
New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease
Lymph Node or Core Needle Biopsy, Fine Needle Aspiration, Tiny Isothermal Nucleic acid Amplification System (TINY) - HIV, Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
Not applicableRecruitingIndiana University5002025-03-172026-08-28
Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma
Blood assessment - B-cell Lymphoma, Hodgkin Lymphoma
Not applicableActive not recruitingCentre Henri Becquerel1082024-12-242025-12-30
Impact of Respiratory Training in Lymphoma Survivors
Inspiratory muscle strength training, Sham Inspiratory muscle strength training - Hodgkin Lymphoma, Non Hodgkin Lymphoma
Not applicableTerminatedUniversity of Colorado, Denver12024-09-162026-02-27
Integrated Actionable Aging Assessment for Cancer Patients Pilot
Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH - Breast Cancer, Hodgkin Lymphoma
Not applicableActive not recruitingUniversity of Colorado, Denver352024-03-012026-11-03
Lifestyle Intervention of Food and Exercise for Lymphoma Survivors
LIFE-L Mediterranean Diet, LIFE-L Home-Based Exercise Program, Supportive Materials - Non Hodgkin Lymphoma, Hodgkin Lymphoma
Not applicableRecruitingUniversity of Miami1402023-04-262026-01-30
Improving Exercise Capacity With a Tailored Physical Activity Intervention
Exercise with Trainerize application, Cardiopulmonary exercise testing, MRI scan - Non Hodgkin Lymphoma, Heart; Functional Disturbance
Not applicableActive not recruitingWake Forest University Health Sciences1052023-03-012026-09-09
Use of Transcranial Photobiomodulation to Improve Cognition and Self-Reported Outcomes in Survivors of Childhood Cancer
Transcranial photobiomodulation (tPBM) - Mobile System - ALL, Hodgkin Lymphoma
Not applicableCompletedSt. Jude Children's Research Hospital442023-01-052026-10-02
Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial
Exercise Intervention, Questionnaire Administration, Telemedicine - Hodgkin Lymphoma, Non-Hodgkin Lymphoma
Not applicableCompletedCity of Hope Medical Center102022-09-142025-10-06
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Virtual group based physical activity (BurnAlong) and Social Media Discussion Board - Cancer, Cancer Metastatic
Not applicableCompletedCedars-Sinai Medical Center82022-07-252025-02-26
MargheRITA (Remote Intelligence for Therapeutic Adherence)
RITA (App) - Multiple Myeloma, Solitary Plasmacytoma
Not applicableCompletedAdvice Pharma Group srl1242022-06-042024-11-06
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
Radiation - Dose Level 0, Radiation - Dose Level 1, Radiation - Dose Level 2 - Non-hodgkin Lymphoma, Hodgkin Lymphoma
Not applicableActive not recruitingUniversity of Chicago302021-09-302025-12-29
Lung Screening in People Cured of Hodgkin Lymphoma
Low dose CT thorax - Hodgkin Lymphoma, Lung Cancer
Not applicableCompletedThe Christie NHS Foundation Trust1022021-08-012024-11-04
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
Health Promotion and Education, Medical Device Usage and Evaluation, Quality-of-Life Assessment - Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Not applicableCompletedOhio State University Comprehensive Cancer Center302021-06-112026-04-06
Evaluation of the Relationship Between Anti-PD-1 Exposure and Tumour VOLUME in Patients Treated for Classical HODgkin's Lymphoma.
blood samples - Hodgkin Lymphoma
Not applicableTerminatedRennes University Hospital72021-04-122023-10-31
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
Pre-biotic foods/drinks - Multiple Myeloma, Acute Myeloid Leukemia
Not applicableCompletedUniversity of Virginia402021-02-192023-01-04
Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers
Home-based cardiac rehabilitation - Lung Cancer, Esophageal Cancer
Not applicableTerminatedWashington University School of Medicine242021-01-152024-07-12
Clinical Investigation of Proton Treatment in Hodgkin Lymphoma Patients - PRO-Hodgkin
Proton therapy. - Hodgkin Lymphoma
Not applicableRecruitingUppsala University Hospital752019-09-012025-03-19

Showing 20 of 36. Sign in to see all of them.

Narrower conditions

Hodgkin Disease (36)  ·  Lymphoma, Non-Hodgkin (21)  ·  Multiple Myeloma (8)  ·  Leukemia, Myeloid, Acute (7)  ·  Lymphoma (6)  ·  Myelodysplastic Syndromes (6)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (6)  ·  Breast Neoplasms (5)  ·  Leukemia (5)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (5)  ·  Myeloproliferative Disorders (5)  ·  Fatigue (3)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Lung Neoplasms (3)  ·  Neoplasms (3)

Broader conditions

Hemic and Lymphatic Diseases (36)  ·  Immune System Diseases (36)  ·  Immunoproliferative Disorders (36)  ·  Lymphatic Diseases (36)  ·  Lymphoproliferative Disorders (36)  ·  Neoplasms by Histologic Type (36)  ·  Neoplasms (33)  ·  Lymphoma (30)  ·  Hematologic Diseases (12)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Neoplasms by Site (10)  ·  Bone Marrow Diseases (9)  ·  Cardiovascular Diseases (9)  ·  Vascular Diseases (9)  ·  Blood Protein Disorders (8)

Interventions

Blood Specimen Collection (2)  ·  Proton Therapy (2)  ·  4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid (1)  ·  Alemtuzumab (1)  ·  Behavior Therapy (1)  ·  Biopsy, Fine-Needle (1)  ·  Biopsy, Large-Core Needle (1)  ·  Brentuximab Vedotin (1)  ·  Cognitive Behavioral Therapy (1)  ·  Cyclophosphamide (1)  ·  Cytarabine (1)  ·  Dacarbazine (1)  ·  Doxorubicin (1)  ·  Educational Status (1)  ·  Enzyme-Linked Immunosorbent Assay (1)

Sponsors

St. Jude Children's Research Hospital (4)  ·  University of Colorado, Denver (2)  ·  Advice Pharma Group srl (1)  ·  Baylor College of Medicine (1)  ·  Case Comprehensive Cancer Center (1)  ·  Cedars-Sinai Medical Center (1)  ·  Center for International Blood and Marrow Transplant Research (1)  ·  Centre Henri Becquerel (1)  ·  City of Hope Medical Center (1)  ·  Indiana University (1)  ·  Leiden University Medical Center (1)  ·  Masaryk University (1)  ·  Mayo Clinic (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Ohio State University Comprehensive Cancer Center (1)

Countries

United States (25)  ·  France (2)  ·  Belgium (1)  ·  Czechia (1)  ·  Germany (1)  ·  Italy (1)  ·  Malawi (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Robert Krance, MD (2)  ·  Alessandro Flavio Ferri (1)  ·  Alexander Lucas, Ph.D. (1)  ·  Amy Berkman, MD (1)  ·  Anita Kumar, MD (1)  ·  Anja Mehnert, Prof. Dr. (1)  ·  Bradford S Hoppe, MD, MPH (1)  ·  Carmen Bergom, M.D., Ph.D. (1)  ·  Celina H Shirazipour, Ph.D. (1)  ·  Craig Moskowitz, MD (1)  ·  Daniel Molin, MD, PhD (1)  ·  Danielle Doria Braman, MSOT, OTR/L (1)  ·  Erin Costanzo, MD (1)  ·  Hien Duong, MD (1)

Results publications

PMID 18258763, PMID 21454450, PMID 24692582, PMID 25195991, PMID 27458003, PMID 33817648, PMID 33909449, PMID 36808045, PMID 37981893, PMID 39620432, PMID 41894682, PMID 42263667

NIH funding

2019 (1), 4UL1TR000427-10 (1), K07CA136966 (1), P01CA015396 (1), P30CA014520 (1), P30CA033572 (1), P50CA244688 (1), R33CA226960 (1), U24HL138660 (1)